Dopamine receptor antagonists impair place conditioning after acute stress in rats

Behavioural Pharmacology

Volumn 21, Issue 1, 2010, Pages 77-82

  Shen, Ying Ling ^a   Chen, Yao Chu ^a   Liao, Ruey Ming ^a  

^a NATIONAL CHENGCHI UNIVERSITY   (Taiwan)

Author keywords

After stress; Association learning; Dopamine; Elevated stand; Raclopride; Rat; Restraint; SCH23390

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; RACLOPRIDE;

ACUTE STRESS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; ATTENUATION; BRAIN LEVEL; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; DOPAMINERGIC SYSTEM; DRUG EFFECT; FOLLOW UP; IMMOBILIZATION STRESS; LOCOMOTION; LOW DRUG DOSE; MALE; NONHUMAN; PLACE PREFERENCE; RAT;

ANIMALS; BENZAZEPINES; CHOICE BEHAVIOR; CONDITIONING, OPERANT; DOPAMINE ANTAGONISTS; MALE; MOTOR ACTIVITY; RACLOPRIDE; RATS; RATS, WISTAR; STRESS, PSYCHOLOGICAL;

EID: 74549184119     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/FBP.0b013e3283359f20     Document Type: Article

References (31)

1. Adams JU, Careri JM, Efferen TR, Rotrosen J (2001). Differential effects of dopamine antagonists on locomotor activity, conditioned activity and conditioned place preference induced by cocaine in rats. Behav Pharmacol 12:603-611.
2. Baker DA, Fuchs RA, Specio SE, Khroyan TV, Neisewander JL (1998). Effects of intraaccumbens administration of SCH-23390 and cocaine-induced locomotion and conditioned place preference. Synapse 30:181-193.
3. Bardo MT, Bevins RA (2000). Conditioned place preference: what does it add to our preclinical understanding of drug reward? Psychopharmacology 153:31-43.
4. Bevins RA, Besheer J (2005). Novelty reward as a measure of anhedonia. Neurosci Biobehav Rev 29:707-714.
5. Cheng RK, Liao RM (2007). Dopamine receptor antagonists reverse amphetamine-induced behavioral alteration on a differential reinforcement for low-rate (DRL) operant task in the rat. Chin J Physiol 50:77-88.
6. Fowler SC, Liou JR (1994). Microcatalepsy and disruption of forelimb usage during operant behavior: differences between dopamine D1 (SCH-23390) and D2 (raclopride) antagonists. Psychopharmacology 115:24-30.
7. Hillegaart V, Ahlenius S (1987). Effects of raclopride on exploratory locomotor activity, treadmill locomotion, conditioned avoidance behaviour and catalepsy in rats: behavioural profile comparisons between raclopride, haloperidol and preclamol. Pharmacol Toxicol 60:350-354.
8. Hiroi N, White NM (1991). The amphetamine conditioned place preference: differential involvement of dopamine receptor subtypes and two dopaminergic terminal areas. Brain Res 552:141-152.
9. Hoffman DC, Beninger RJ (1985). The D1 dopamine receptor antagonist, SCH23390 reduces locomotor activity and rearing in rats. Pharmacol Biochem Behav 22:341-342.
10. Inglis FM, Moghaddam B (1999). Dopaminergic innervation of the amygdala is highly responsive to stress. J Neurochem 72:1088-1094.
11. Inoue T, Izumi T, Maki Y, Muraki I, Koyama T (2000). Effects of dopamine D1/5 antagonist SCH23390 on the acquisition of conditioned fear. Pharmacol Biochem Behav 66:573-578.
12. Joels M, Pu Z, Wiegert O, Oitel MS, Krugers HJ (2006). Learning under stress: how does it work? Trends Cogn Sci 10:152-158.
13. Kafka SH, Corbett R (1996). Selective adenosine A2A receptor/dopamine D2 receptor interactions in animal models of schizophrenia. Eur J Pharmacol 295:147-154.
14. Liao RM (2008). Development of conditioned place preference induced by intra-accumbens infusion of amphetamine is attenuated by co-infusion of dopamine D1 and D2 receptor antagonists. Pharmacol Biochem Behav 89:367-373.
15. Liao RM, Chang YH, Wang SH (1998). Influence of SCH23390 and spiperone on the expression of conditioned place preference induced by d-ampheta-mine or cocaine in the rat. Chin J Physiol 41:85-92.
16. Liao RM, Chang YH, Wang SH, Lan CH (2000). Distinct accumbal subareas are involved in place conditioning of amphetamine and cocaine. Life Sci 67:2033-2043.
17. Meririnne E, Kankaanpaa A, Seppala T (2001). Rewarding properties of methyphenidate: sensitization by prior exposure to the drug and effects of dopamine D1-and D2-receptor antagonists. J Pharmacol Exp Ther 298:539-550.
18. Pezze MA, Feldon J (2004). Mesolimbic dopaminergic pathways in fear conditioning. Prog Neurobiol 74:301-320.
19. Puglisi-Allegra S, Imperato A, Angelucci L, Cabib S (1991). Acute stress induces time-dependent responses in dopamine mesolimbic system. Brain Res 554:217-222.
20. Roth RH, Tam SY, Ida Y, Yang JX, Deutch AY (1988). Stress and the mesocorticolimbic dopamine system. In: Kalivas PW, Nemeroff CR, editors. Annals of New York Academy of Sciences, Vol.537: The mesocorticolimbic dopamine system. New York: The New York Academy of Sciences. pp. 138-147.
21. Saal D, Dong Y, Bonci A, Malenka RC (2003). Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron 37:577-582.
22. Salamone JD (1994). The involvement of nucleus accumbens dopamine in appetitive and aversive motivation. Behav Brain Res 61:117-133.
23. Sapolsky RM (2004). Stress and cognition. In: Gazzaniga MS, editor. The cognitive neuroscience III. Cambridge: MIT press. pp. 1031-1042.
24. Shen YL, Liao RM (2007). The effects of acute stress on conditioned place preference. Chin J Psychol 49:351-363. (in Chinese).
25. Shors TJ (2001). Acute stress rapidly and persistently enhances memory formation in the male rat. Neurobiol Learn Mem 75:10-29.
26. Shors TJ (2004). Learning during stressful times. Learn Mem 11:137-144.
27. Simon VM, Parra A, Minarro J, Arenas MC, Vinader-Caerols C, Aguilar MA (2000). Predicting how equipotent doses of chlorpromazine, haloperidol, sulpiride, raclopride and clozapine reduce locomotor activity in mice. Eur Neuropsychopharmal 10:159-164.
28. Solomon RL, Corbit JD (1974). An opponent-process theory of motivation. I. Temporal dynamics of affect. Psychol Rev 81:119-145.
29. Timothy C, Costall B, Smythe JW (1999). Effects of SCH23390 and raclopride on anxiety-like behavior in rats tested in the black-white box. Pharmacol Biochem Behav 62:323-327.
30. Tzschentke TM (1998). Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog Neurobiol 56:613-672.
31. Tzschentke TM (2007). Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict Biol 12:227-462.